Clinical Trial Results Archive

Clinical Trial Results: February 2007

February 13	Study Published in British Medical Journal The Lancet Shows Aromasin Improves Overall Survival in Breast Cancer Patients
February 13	BioLineRx Successfully Completes Phase 1 Clinical Trials of BL-1020, First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia
February 13	New Survey Reveals Nurses and Patients See Limitations of Commonly Used Method of Postoperative Pain Management
February 13	Flu Shot Might Also Offer Some Protection Against H5N1
February 14	Peregrine Pharmaceuticals Reports Positive Phase Ib Results for its Targeted Immunotherapy Bavituximab in Chronic Hepatitis C Infection
February 14	Genta Cites Publication of Study Showing Improved Outcomes in CLL Patients Treated With Genasense Plus Chemotherapy
February 14	Clinical Data Supporting Development of ChemGenex's Ceflatonin in Imatinib-Resistant CML Published in Cancer
February 14	Morria Biopharmaceuticals Plc. Announces Publication of the Results of Its Human Pilot Study in Contact Dermatitis Patients of MRX1, a Novel First-in-Class MFAID
February 14	Study Assesses New Communication Techniques Designed to Improve Dialogue About Migraine Between Healthcare Professionals and Patients
February 14	New Instrument Developed to Measure Impact of Migraine on Patients' Lives When They Are Not Experiencing an Attack
February 14	Protein Sensor for Fatty Acid Buildup in Mitochondria
February 14	Genta Cites Publication of Study Showing Improved Outcomes in CLL Patients Treated with Genasense Plus Chemotherapy
February 14	Hemispherx Avian Flu Prevention/Treatment Program Announces New Primate Results and Expands in both Europe and Southern Hemisphere
February 14	Halozyme Therapeutics and Baxter Present Promising Results for the Use of Hylenex From the Infuse-Morphine Study
February 15	The Immune Response Corporation's Interim Phase II Data Suggest Both REMUNE and IR103 Stabilize CD4+ Cell Counts in Drug-Naive HIV Patients
February 15	Unique Structure of Geron's Telomerase Inhibitor Drug Promotes Anti-Tumor, Anti-Metastatic Activity in Lung Cancer Cells
February 15	Alagebrium Demonstrates Cardiovascular Activity in Recently Published Report Indicating Potential Wide-Ranging Benefits in Cardiovascular Diseases
February 15	Positive Results with Lacosamide in Diabetic Neuropathic Pain in Phase III Trial
February 15	Survey Finds Perceived Risk of Recurrence is Low in African American Breast Cancer Survivors
February 15	Gene Network Sciences and UCSD Researchers Discover Connection Between Metabolic Pathways and Cancer
February 15	Nasal Flu Vaccines Provide 'Double' Immunity, Carrington Labs Says
February 15	CDC Report Provides First State-Specific Data on Persons Living With Heart Disease
February 15	Researchers Discover New Details About HIV-1 Entry and Infection
February 15	OXiGENE Announces Positive Results from its Phase II CA4P Clinical Trial in Myopic Macular Degeneration (MMD-213)
February 16	Inovio Biomedical DNA Delivery Technology Presented by Wyeth Researcher at Vaccine Conference
February 16	Preclinical Efficacy Data on Medivation's MDV3100 to Be Presented at ASCO-sponsored Prostate Cancer Symposium
February 16	New Study Shows Cough Medicine Effective Against Prostate Cancer
February 16	GPC Biotech Schedules Conference Call to Discuss Results from the Satraplatin Phase 3 Trial Being Presented at the ASCO Prostate Cancer Symposium in Orlando, Florida
February 16	Researchers Discover "Sticky" Proteins Fuse Adult Stem Cells to Cardiac Muscle, Repairing Hearts
February 16	Mayo Clinic Investigators Demonstrate Degradation of Key Abnormal Alzheimer's Disease Protein
February 16	Amgen to Hold Analyst Call to Discuss Danish Head and Neck Cancer (DAHANCA) 10 Study
February 20	Auxilium Announces Results from Phase III Trial that Show AA4500 Successful in Treating Dupuytren's Contracture
February 20	Vyteris Releases Study Estimating the Market for Lidosite Between $200M - $500M for Use Prior to Blood Draws
February 20	Alteon's Investigational Drug Alagebrium Demonstrates Ability to Improve Functional Membrane Transport in a Rat Model of Chronic Peritoneal Dialysis, Indicating a Potential Role in Kidney Disease
February 20	Basilea Reports Positive Phase III Results for Alitretinoin
February 20	BioMarin Announces Results From Phase 2 Clinical Study of 6R-BH4 in Poorly Controlled Hypertension
February 20	CeNeS Pharmaceuticals plc Announces Successful Phase III Results on Lead Product M6G
February 20	Psoriasis Foundation Consensus Statement Examines Psoriasis Severity in a New Light
February 20	H. Lee Moffitt Researchers Discover Potential Targets to Reduce Risk of Stem Cell Transplants
February 20	New Data Support AlphaVax's Vaccine for CMV
February 20	The Medicines Company Supports Landmark Patient Observational Study and Clinical Survey on Acute Severe Hypertension
February 20	Researchers Funded by The Leukemia & Lymphoma Society Studying Agent to Target Gene Linked to Many Forms of Lymphoma
February 20	RNAi Shows Promise in Gene Therapy, Stanford Researcher Says
February 20	Stanford Q&A: Largest-Ever Study Shows Possible Genetic Links for Autism
February 20	Successful Phase III results announced on Lead Product M6G
February 20	FDA Warns About Erythropoiesis Stimulating Agents (ESAs) - Results of Aranesp Study May Apply to Other ESAs
February 20	Largest-Ever Search for Autism Genes Reveals New Clues
February 21	GTx Announces Presentation of Acapodene Data At ASCO Prostate Cancer Symposium
February 21	BioSante Pharmaceuticals to Present LibiGel at International Society for the Study of Women's Sexual Health (ISSWSH) Annual Meeting
February 21	Sepracor Announces Publication of Additional Data from Lunesta Insomnia-Depression Study in the Journal of Clinical Sleep Medicine
February 21	Pre-Clinical Study of Novavax's Seasonal Influenza Vaccine Published in Journal 'Vaccine'
February 21	New Long-term Data Published in Journal of Clinical Oncology Support That Femara Is More Effective Than Tamoxifen
February 21	Experimental Vaccine Given During Pregnancy Reduces Stillbirths from Common Virus
February 22	Hollis-Eden Pharmaceuticals Presents Additional Positive Data with Novel Steroid Hormone in Models of Prostate and Breast Cancer
February 22	Poniard Pharmaceuticals Announces Picoplatin Abstract Accepted for Publication by ASCO's 2007 Prostate Cancer Symposium
February 22	Cell Genesys and Medarex Announce Encouraging Follow-Up Results from a Phase 1 Combination Therapy Trial With GVAX Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
February 22	Analysis of International Phase III Study of Avastin Plus Chemotherapy Shows Improved Progression-Free Survival in Patients With Advanced Lung Cancer
February 22	Allegiance Equity Corporation Announces Positive Results of In Vitro Studies and an Open Label Trial for Relieva in Treating Atopic Dermatitis
February 22	Cell Genesys and Medarex Announce Encouraging Follow-Up Results from a Phase 1 Combination Therapy Trial With GVAX(TM) Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
February 22	MediciNova to Present Phase II Clinical Trial Results for MN-001, a Novel Oral Treatment for Bronchial Asthma, at the 2007 AAAAI Annual Meeting
February 22	CureDM, Inc. Achieves Two Drug Discovery Milestones
February 23	GTx's ACAPODENE Interim Bone Mineral Density and Lipid Data Highlighted at Press Briefing at Prostate Cancer Symposium of the American Society of Clinical Oncology
February 23	Spectrum Pharmaceuticals Announces Satraplatin Data Presentation at the American Society of Clinical Oncology Prostate Cancer Symposium
February 23	Satraplatin Shown to Significantly Reduce Risk of Disease Progression in Advanced Hormone-Refractory Prostate Cancer Patients
February 23	Significant Phase III Results With Cimzia in Rheumatoid Arthritis
February 23	Defibrotide Highlighted in Presentation at the 51st Meeting of the German Society for Thrombosis and Hemostasis
February 23	Update on Cortex's CEO Presentation at the Roth Capital Partners 19th Annual Conference
February 23	Crutchfield Dermatology Reports a New Wrinkle in the Quest for Smooth and Youthful Skin
February 23	Dynavax Reports Interim, One-Year Data From Ragweed Allergy Trial at AAAAI
February 23	Dynavax Announces Webcast on AAAAI Data and 2007 Financial Outlook
February 23	Treatment Extends Survival in Mouse Model of Spinal Muscular Atrophy
February 23	Gamunex Is the Preferred Liquid IGIV Therapy Among Allergists and Immunologists Surveyed
February 23	Protox Announces PRX302 Data to Be Presented at ASCO Sponsored Prostate Cancer Symposium
February 23	Positive AS1404 Trial Data Presented at ASCO Prostate Cancer Symposium
February 23	Cougar Biotechnology Announces Presentation of Positive Phase I and Phase II Data at ASCO Prostate Cancer Symposium
February 26	'Encouraging' Major Responses Seen With Xyotax in Patients With Taxane-Resistant Androgen Independent Prostate Cancer
February 26	Palatin Technologies and King Pharmaceuticals Announce Presentation Regarding Clinical Study Evaluating Bremelanotide in Post-Menopausal Female Sexual Dysfunction Patients
February 26	Physicians Still Treating Acute Otitis Media (AOM) as They Did Prior to PCV-7
February 26	LifeCycle Pharma Announces Positive Data From LCP-AtorFen Phase I Clinical Program
February 26	Steroid-Free Astelin Nasal Spray Demonstrated Seasonal Allergy Symptom Improvement Within 15 Minutes in Clinical Study
February 26	Drug Treatment Improves Learning in Mice With Down Syndrome Symptoms, Stanford/Packard Study Shows
February 26	Hollis-Eden Pharmaceuticals Reports Publication of Results Demonstrating the Ability of Neumune to Increase Survival in a Primate Model of Lethal Radiation Injury
February 26	Othera Pharmaceuticals Presents New AMD Data at Angiogenesis 2007 Symposium
February 26	Phase 3 Stroke Trial Shows That Novoseven Reduces Bleeding in the Brain, but Does Not Improve Long-term Clinical Outcomes
February 26	Survey Shows Discomfort With Existing Nasal Sprays Causes Allergic Rhinitis Patients to Discontinue Treatment
February 26	Medivation's MDV3100 Shown to Be Effective in a Preclinical Model of Hormone-Refractory Prostate Cancer
February 26	Gilead Announces Completion of Phase II Clinical Trial of Novel Investigational HIV Integrase Inhibitor GS 9137
February 26	Algeta's Alpharadin significantly improves patient survival in a clinical trial in prostate cancer
February 26	Avigen's AV411 Highlighted in Special Issue of Neuron Glia Biology
February 26	New Clinical Data for Prostascint and Quadramet in Prostate Cancer Presented at the 2007 Prostate Cancer Symposium
February 26	Phase 2 Results of Genasense Plus Chemotherapy in Advanced Prostate Cancer Reported at Cancer Conference
February 26	LifeCycle Pharma announces positive data from LCP-AtorFen Phase I clinical program
February 27	MAP Pharmaceuticals Reports Positive Phase 2 Results for its Pediatric Asthma Drug Candidate
February 27	Post-Hoc Data Analyses Published in Annals of Neurology Found Copaxone Significantly Delayed Accumulated Disability in Male Patients with Primary Progressive Multiple Sclerosis (PPMS)
February 27	Increased Prescription Drug Co-pays Linked to Lower Medication Usage and Higher Hospitalization Rates, Thomson Medstat Study Finds
February 27	Reported to the American Academy of Allergy, Asthma and Immunology: Pittsburgh Study Suggests Asthma Medication May Provide Relief for the Common Cold
February 27	MatTek's EpiVaginal Excels in Microbicide/HIV Research Study
February 27	Podcast Alert: Dr. Eli Meltzer Discusses New Data on Fluticasone Furoate Nasal Spray
February 27	Studies Showed Fluticasone Furoate Nasal Spray Was Well-Tolerated and Effective in Treating Allergic Rhinitis in Pediatric Patients
February 27	New Data Showed Fluticasone Furoate Nasal Spray Effectively Treated Nasal Symptoms of Allergic Rhinitis
February 27	Study Finds C1-Inhibitor Concentrate Is Safe and Effective in Treating Skin Swelling in Patients With Hereditary Angioedema
February 27	Genitope Corporation to Host Conference Call to Discuss Updated Blinded Data from Its Phase 3 Clinical Trial
February 28	TargeGen Announces Successful Completion of Phase I Clinical Trial of Topical AMD Drug TG100801
February 28	Beech Tree Labs' ML-05 Addresses External and Internal Scars
February 28	Nymox Reports Completion of New Long-term Study of NX-1207 for BPH
February 28	Mayo Clinic Researchers Safely Regenerate Failing Mouse Hearts With Programmed Embryonic Stem Cells
February 28	IL-1 Trap Phase 3 Trial Data Presented at Annual Meeting of American Academy of Allergy, Asthma and Immunology (AAAAI)
February 28	Human Genome Sciences Announces Positive Interim Results of Phase 2b Trial of Albuferon With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
February 28	Review of 1918 Pandemic Flu Studies Offers More Questions than Answers

Clinical Trial Results Archive

2008: Jan | Feb | Mar | Apr | May
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Dec

More News Resources

Pharma News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals

	A to Z Drug List	Drugs by Condition	Pill Identifier	Drug Interactions Checker	Medical Encyclopedia	Medical Dictionary	Pharmaceutical News & Articles	Community Forums
Welcome Guest\|Register or Sign In My Viewing History \| My Drug List \| My Interactions Lists \| Member Offers